FOURNITURE 'D'ANASTROAZOLE, ANAGRELIDE, LETROZOLE, BEVACIZUMAB, BORTEZOMIB ET DE FULVESTRANT 2023-2027
Buyer: HUmani SC
- Published
- 12 January 2024
- Place of performance
- Lodelinsart, BE32B
- Procedure
- open
- Lots
- 6
- Notice number
- 00022439-2024
- Reference
- ccb4192f-af34-438e-9d2f-caea06578461
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
Le présent marché à lots a pour objet la fourniture d'anastroazole, d'anaglélide, de létrozole, de bévacizumab, de bortézomib et de fulvestrant dans différents dosages et formes galéniques.
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Eurogenerics | €966,236 | — |
| Viatris bv | €698,818 | — |
| Celltrion Healthcare Netherlands BV | €659,869 | — |
| Sandoz | €91,283 | — |
| Arega Pharma BV | €83,778 | — |
| Pharmanovia Benelux B.V. | €80,187 | — |
| ACCORD HEALTHCARE BVBA | €73,984 | — |
| Pharmanovia Benelux B.V. | €67,015 | — |
| Arega Pharma BV | €36,636 | — |
| Eurogenerics | €33,120 | — |
Frequently asked questions
- Who is the buyer of this tender?
- The contracting authority is HUmani SC (European Union).
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.